Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

B&L'S CHIRON VISION PURCHASE COULD INCLUDE FDA-APPROVED REFRACTIVE LASER

This article was originally published in The Gray Sheet

Executive Summary

Bausch & Lomb's acquisition of Chiron Vision could put it in the U.S. refractive laser surgery market. Chiron Vision has a premarket approval application pending for a refractive excimer laser, and expects a decision from FDA by the end of the year. B&L announced a definitive agreement to buy Chiron Vision for $300 mil. cash on Oct. 20; the deal is expected to close in early 1998.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009002

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel